Online pharmacy Phlo secures new chief pharmacist

Glasgow-based online pharmacy Phlo Technologies has announced the appointment of Alistair Murray as its chief pharmacist.

Alistair Murray is “already hard at work” helping Phlo maintain its “impressive momentum”

Phlo offers patients same-day medicine delivery, with bases in Glasgow, London, Birmingham and Manchester and some 25% of England’s population in its “catchment area” for same-day deliveries.

Read more: Safety first: Medino’s superintendent on running an online pharmacy

The online pharmacy announced Mr Murray as its new chief pharmacist yesterday (July 31). Mr Murray, an independent prescriber and “digital pharmacy compliance expert”, was previously the founding clinician at Echo, which was subsequently bought by Lloydspharmacy in 2019 and rebranded to Lloydsdirect

“Impressive momentum”

Mr Murray said that he was “already hard at work” helping the company maintain its “impressive momentum” and grow further.

“As the Phlo chief pharmacist, I will be working closely with the team and our partner organisations to ensure the continued success of our regional expansion and new product development,” he added.

Read more: There’s an app for that: Can technology bring pharmacists closer to patients?

Adam Hunter, Phlo’s chief commercial officer, said that Mr Murray would contribute “a perfect mix of perspective and insight” to the company.

He continued: “His unique combination of clinical and regulatory experience and his track record in digital pharmacy make him the ideal person to take on the role of chief pharmacist.”

Phlo also operates Phlo Connect, a pharmacy application programming interface (API) that allows prescribers to send and monitor prescriptions, according to the company’s website.

Read more: Online pharmacy expansion secures ‘six-figure’ backing from HSBC UK

In February this year, Phlo raised £10 million in a stock sale to fund its expansion across the UK.

And in April, the company announced that it had bought the UK branch of Truepill, a US-based online pharmacy, for an undisclosed sum.

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.